Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 8 at 2:00 PM EDT

Register Free →
logo
Get CLEATUSFree Trial

REGAGENTS TEST KITS

Active
N3239826Q4854Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The United States Department of the Naval Medical Research Command is procuring specialized reagent kits and consumables from Illumina Inc. under a non-competitive contract based on sole-source authority for brand-name equipment. The requirement includes a comprehensive list of Illumina products essential for respiratory pathogen detection and genomic analysis, such as multiple sets of Respiratory Virus Enrichment Kits, Respiratory Pathogen ID/AMR Enrichment Kits, DNA/RNA UD Indexes, XLEAP-SBS and MiSeq reagent kits, and the PhiX Control v3. These materials are critical for high-throughput sequencing and molecular surveillance activities conducted by the military medical research community. All items are designated for research use only, with specific catalog numbers clearly identified to ensure exact product alignment. procurement is governed under FAR Part 12 as a commercial item acquisition, with the NAICS code 541714 assigned to laboratory research and development services. Vendors must be registered in the System for Award Management and possess a Unique Entity Identification Number to be eligible for award, with no exceptions permitted. The solicitation number is N3239826Q4854, with responses due by July 17, 2026, and all proposals should be directed to the designated point of contact at the Naval Medical Research Center in Silver Spring, Maryland. While this is not a competitive solicitation, the government will evaluate capability statements submitted by interested parties to confirm suitability and compliance with operational needs.

General Info

U.S. Navy procures sole-source Illumina reagents for respiratory pathogen sequencing via non-competitive contract.

Agency

Department Of Defense → Naval Medical Research CenterView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

MD

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

special-notice

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Naval Medical Research Center
Contacts2 people available
OfficeSILVER SPRING, MD, 20910-7500, USA
Organization / Agency
Department Of Defense → Naval Medical Research Center
View Agency Profile
Office AddressSILVER SPRING, MD, 20910-7500, USA
Contacts
Nataki JOHNSON
contact@example.gov
Shamai Carter
contact@example.gov

Full Description

Show more
The United States Department of the Naval Medical Research Command (NMRC) proposes to enter into a contract with Illumina Inc. in San Diego CA, on a basis of other than full and open competition. This requirement is for authorized approved vendors to perform services for brand name equipment. This notice is not a request for competitive proposals however If interested, the Government shall consider capability statements.
This requirement includes:
Illumina Cat#:20100469, Illumina Respiratory Virus Enrichment Kit Set A (96 indexes, 96 samples) Illumina Cat#: 20100470, Illumina Respiratory Virus Enrichment Kit Set B (96 indexes, 96 samples) Illumina Cat#: 20100471, Illumina Respiratory Virus Enrichment Kit Set C (96 indexes, 96 samples) Illumina Cat#: 20100472, Illumina Respiratory Virus Enrichment Kit Set D (96 indexes, 96 samples) Illumina Cat#: 20044311, Respiratory Virus Oligos Panel V2 Illumina Cat#: FC-110-3001, PhiX Control v3 Illumina Cat#: 20100982, NextSeq(TM) 1000/2000 P1 XLEAP-SBS(TM) Reagent Kit (300 Cycles) Illumina Cat#: 20126568, MiSeq i100 Series 25M Reagent Kit (300 cycles) Illumina Cat#: 20047050, Respiratory Pathogen ID/AMR Enrichment Kit Set A (RUO) (96 indexes, 96 samples) Illumina Cat#: 20046969, Respiratory Pathogen ID/AMR Enrichment Kit Set B (RUO) (96 indexes, 96 samples) Illumina Cat#: 20091654, Illumina(r) DNA/RNA UD Indexes Set A, Tagmentation (96 Indexes, 96 Samples) Illumina Cat#:20091656, Illumina(r) DNA/RNA UD Indexes Set B, Tagmentation (96 Indexes, 96 Samples) Illumina Cat#: 20091658, Illumina(r) DNA/RNA UD Indexes Set C, Tagmentation (96 Indexes, 96 Samples) Illumina Cat#: 20091660, Illumina(r) DNA/RNA UD Indexes Set D, Tagmentation (96 Indexes, 96 Samples) Illumina Cat#: 20100985, NextSeq(TM) 1000/2000 P2 XLEAP-SBS(TM) Reagent Kit (300 Cycles) Illumina Cat#: 20141599, MiSeq(TM) i100 Plus 100M Reagent Kit (300 cycles) Illumina Surcharge
The NAICS code for this action is 541714. This requirement will be procured under the guidelines of FAR Part 12 Commercial Items. NMRC requires that all contractors doing business with the Acquisition Office must be registered with the Systems for Award Management (SAM). No award can be made unless the vendor is registered in Systems for Award Management. For additional information and to register in SAM, please access the following website: https://www.sam.gov/. In order to register with the SAM and to be eligible to receive an award from this Acquisition Office, all offers must have a Unique Entity Identification Number (UEI). A Sam.gov number may be acquired free of charge by contacting Sam.gov online at www.sam.gov or by phone at (866) 606-8220

Similar Contracts

NAICS: 541714
New
Federal
Notice of Intent contact activation pathway function blocking antibody AB023The Defense Health Agency, through its Contracting Activity, intends to award a sole-source contract to Oregon Health & Science University for the supply of the contact activation pathway function blocking antibody AB023, in support of the United States Army Institute of Surgical Research. This determination follows a prior Request for Information that received no responses, leading the government to conclude that OHSU is the only viable source capable of fulfilling this specialized requirement. The contract action is classified under NAICS code 541714, which pertains to research and development in the physical, engineering, and life sciences, with a size standard of 1,000 employees. The solicitation number is HT9426-26-NOI-WS03, and while this notice is not a solicitation for competitive bids, responsible parties may still submit capability information by July 9, 2026, to demonstrate their ability to meet the requirement, though such submissions will only inform the government’s decision on competitiveness and carry no cost reimbursement. All submissions must be sent via email to the designated point of contact by the deadline, and the government retains full discretion to proceed with non-competitive award. The primary performance location is in San Antonio, Texas, while the contracting office is based in Fort Detrick, Maryland.
Defense Health Agency

POSTED

2 days ago

DEADLINE

in 14 days
View Details
NAICS: 541714
New
Federal
Advancing Autonomous Science for Biological Applications RFIThe Defense Advanced Research Projects Agency’s Biological Technology Office is soliciting input from the scientific and technical community to assess the current state of autonomous science in biological applications and identify high-potential opportunities for investment. This request for information aims to guide future research and development priorities that align with national security objectives and broader public benefit, with a focus on technologies that enable machines to independently design, execute, and interpret biological experiments without direct human intervention. Responses are requested by July 22, 2026, and should address advancements in automation, artificial intelligence, robotics, and data integration within biological research domains. All submissions must be directed to Dr. Russell Schwartz, Program Manager at DARPA/BTO, via the email AutoSci-RFI@darpa.mil, and the opportunity is classified under NAICS code 541714 for Research and Development in the Physical, Engineering, and Life Sciences. The request is open to the public with no set-aside requirements, and responses will inform potential future funding initiatives rather than constitute a solicitation for immediate contracts. Interested parties are encouraged to provide detailed technical insights, emerging innovations, and challenges in autonomous biological science to help shape the agency’s strategic investments in this rapidly evolving field.
Defense Advanced Research Projects Agcy

POSTED

2 days ago

DEADLINE

in 27 days
View Details
NAICS: 541714
New
Federal
Vector-borne Disease Agent Surveillance Research & Development in External Proficiency TestingThe contract seeks a Firm-Fixed Price award for research, development, and validation of field-expedient external proficiency testing procedures to detect pathogens in arthropods, specifically mosquitoes, using non-infectious agents to minimize risk and ensure safety. The work, titled Vector-borne Disease Agent Surveillance Research & Development in External Proficiency Testing, is managed by the Defense Health Agency under the Department of Defense and is assigned NAICS code 541714 for Research and Development in Biotechnology. The performance period spans one year from September 30, 2026, to September 29, 2027, with key deliverables including a kickoff meeting within 15 days of award, a draft and final written manual for safe proficiency testing, a comprehensive validation report documenting accuracy, precision, analytical sensitivity, and specificity, and a results package with statistically valid data from at least 60 samples. All work is unclassified, with Controlled Unclassified Information (CUI) handling applicable, while Personally Identifiable Information and Protected Health Information requirements do not apply. The Government intends to obtain unlimited rights in all data and deliverables to support force health protection and potential transition to other entities. Submissions must be structured into two volumes: Volume I, the Technical Capabilities section, limited to ten pages, detailing technical expertise in external quality assurance, quality control measures, sourcing, delivery approach, and schedule adherence; and Volume II, the Price section, with no page limit but requiring unit and total prices for the single contract line item. Quotes must be submitted electronically by June 16, 2026, in Word, Excel, or searchable PDF format, with zip files prohibited. Offerors must maintain active SAM registration and submit completed provisions 52.219-1 and 252.204-7017. Technical proposals must achieve at least an "Acceptable" rating and the proposed price must be deemed complete and reasonable as mandatory pass/fail gates; award will be made based on the most advantageous offer considering both technical merit and price, without negotiations. Contract administration relies on the Wide Area WorkFlow system for payments, with tailored instructions for cost-type and fixed-price deliverables, and is governed by a Quality Assurance Surveillance Plan that defines performance standards, surveillance frequency, and defect thresholds. The Contracting Officer’s Representative provides oversight but lacks authority to modify contract terms. Compliance with clauses on convict labor, prohibitions on inverted corporations, confidentiality agreements, trafficking in
Defense Health Agency

POSTED

2 days ago

DEADLINE

in 4 days
View Details
NAICS: 541714
New
Grant
Site-Specific Clinical Research Study ExecutionThe contract requires the design and execution of a focused clinical research project examining outcomes related to spinal cord injury in the domains of health, employment, or community living. The awardee must obtain IRB approval, recruit eligible participants, deliver the assigned intervention, and systematically measure outcomes using validated methods. This work is conducted as a subcontract under the Administration for Community Living within the Department of Health and Human Services and is aligned with research priorities aimed at improving quality of life for individuals with spinal cord injuries. All activities must adhere to ethical standards and federal research guidelines, with full responsibility for study implementation resting with the contractor. The project is governed under NAICS code 541714, indicating a focus on research and development in the social sciences and humanities. The solicitation was posted on June 22, 2026, with responses due by July 29, 2026. There is no set-aside designation specified, and the place of performance details are not provided, implying flexibility in location as long as the research objectives are met. The award is structured as a subcontract, suggesting it supports broader federal efforts to advance SCI recovery and integration outcomes. The contractor must demonstrate capacity in human subjects research, clinical study logistics, and outcome measurement to successfully fulfill the scope.
Administration For Community Living

POSTED

3 days ago

DEADLINE

in about 1 month
View Details
NAICS: 541714
New
Federal
Infinium Global Diversity Array Kits.The National Institutes of Health, through its Office of Logistics and Operations, is conducting a non-competitive, sole-source acquisition under FAR Part 13 for technical support services related to the Infinium Methylation Global Diversity Array Kits, with a simplified acquisition ceiling of $350,000. This procurement is justified based on Illumina, Inc.’s exclusive and irreplaceable capability to provide specialized technical support through its dedicated team of Technical Applications Scientists and Field Application Scientists, who possess unmatched expertise in troubleshooting the proprietary Infinium assay system. Only Illumina can deliver free-of-charge replacement reagents in the event of assay failure due to product performance, a critical requirement that no other vendor can meet. The acquisition is issued under NAICS code 541714 and is open to businesses certifying their size status as small or other than small based on the $34 million annual receipts threshold, with all offerors required to maintain active SAM registration and provide a Unique Entity ID and Taxpayer Identification Number. The contract performance location is Bethesda, Maryland, and proposals must be submitted electronically via email to the designated point of contact by the July 2, 2026 deadline. No formal evaluation factors, line items, pricing details, or packaging requirements are specified, as this is a presolicitation notice relying entirely on the unique technical capabilities of the sole source. Acceptance criteria are implicitly tied to the contractor’s ability to sustain assay performance through timely troubleshooting and replacement reagents. The contract type is unspecified, and no options, security clearances, key personnel, or organizational conflict of interest provisions are included, as the acquisition is narrowly focused on the singular technical support needs tied to Illumina’s proprietary platform.
National Institutes Of Health Olao

POSTED

3 days ago

DEADLINE

in 7 days
View Details